MORE►
gene therapy
![R.A. Session II, president, CEO, and founder of Taysha Gene Therapies [Background image: Olena Yepifanova via iStock]](https://s24806.pcdn.co/wp-content/uploads/2020/04/TayshaGene-Session-970-1-940x436.jpg)
R.A. Session II, president, CEO, and founder of Taysha Gene Therapies [Background image: Olena Yepifanova via iStock]
Dallas Gene Therapy Startup Closes $95M Series B to Bolster its Initial Clinical Studies
by Quincy Preston and Alex Edwards | Aug 5, 2020
Taysha Gene Therapies, which was been operating in stealth with UT Southwestern until this April, plans to use the financing to advance its initial cohort of lead programs into its clinic. By the end of 2021, Taysha expects to file four Investigational New Drug applications.
by Lance Murray |
Sep 13, 2019
In this weekly roundup of research and development activity in North Texas, you’ll also read about how an SMU professor and students from Garland High School are using smartphone data to monitor a local bridge’s health.
MORE►
by Lance Murray |
Sep 12, 2019
Together, the two companies aim to increase access to complex medications and ensure that patients more quickly receive the correct drug at the right time.
MORE►
by Natalie Le |
Jul 30, 2019
Providing integrated solutions ranging from discovery to engineering, biologics CRDMO LakePharma made its Dallas debut earlier this summer.
MORE►
